Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,290.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 3,170.00
  • 52 Week Low: 2,072.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 73,384
  • Market Cap: £1,523.75m
  • RiskGrade: 128
  • Beta: 0.01

Genus Overview

Genus plc is a United Kingdom-based animal genetics company. It supplies breeding animals with desirable characteristics to farmers, enabling them to produce quality meat and milk. The Company's segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.5% 0.0%
Div Cover 2.6 3.0
Op Mrgn 6.3% 13.8%
ROCE 7.8%  
Latest F'cast
P/E 26.1 29.0
PEG 1.0 1.3
Pr/Revenue 2.1 2.7
Pr/Book 3.0  
Latest F'cast
Revenue 0.6% 0.5%
PBT 418.2% 227.0%
EPS 24.9% 28.2%
DPS n/a 8.1%

Genus Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 574.30 55.80 100.90p 49.2 1.6 +30% 32.00p 0.6%
30-Jun-22 593.40 48.40 82.70p 30.3 n/a -18% 32.00p 1.3%
30-Jun-23 689.70 39.40 84.80p 25.5 12.8 +2% 32.00p 1.5%
30-Jun-24 668.80 5.50 65.50p 25.2 n/a -23% 32.00p 1.9%
30-Jun-25 672.80 28.50 81.80p 25.0 1.0 +25% 32.00p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Genus Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 676.01 93.21 104.89p 21.8 0.8 +28% 34.60p 0.0%
30-Jun-27 686.55 89.08 103.82p 22.1 n/a -1% 35.88p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Genus Company Announcements

Director/PDMR Shareholding 29-Jun-2026 11:34 RNS
Holding(s) in Company 16-Jun-2026 08:28 RNS
Director/PDMR Shareholding 13-May-2026 12:32 RNS

Genus ShareCast News

Director dealings: Genus non-executive director ... 29-Jun-2026 ShareCast
Genus shares slide on record profit as investors... 26-Feb-2026 ShareCast
Genus hails successful formation of Chinese porc... 02-Feb-2026 ShareCast

Genus Top Newspaper Links

GENUS PROFIT BOOSTED 07-Sep-2011 Express & Star
Genus shares jump on bid talk 20-May-2008 The Scotsman
SLI’s high flyer pushes toward UK’s top slot 24-Dec-2007 The Herald

Latest Genus Director Deals

Traded Action Notifier PriceAmountValue
26-Jun-26 Buy Celia Baxter 2,139.51p 2,336 £49,979.00
13-May-26 Sell Jorgen Kokke 2,267.00p 3,450 £78,211.50
13-May-26 Exercise of option Jorgen Kokke 0.000p 7,649 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Genus Market Data

Currency UK Pounds
Share Price 2,290.00p
Change Today -22.00p
% Change -0.95 %
52 Week High 3,170.00
52 Week Low 2,072.00
Volume 73,384
Shares Issued 66.54m
Market Cap £1,523.75m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 06-Nov-25
Paid 27-Mar-26 05-Dec-25
Amount 11.20p 21.70p

Trades for 03-Jul-2026

Time Volume / Share Price
16:35 33 @ 2,290.00p
16:35 358 @ 2,290.00p
16:35 202 @ 2,290.00p
16:35 807 @ 2,290.00p
16:35 30,656 @ 2,290.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page